RUSSELL FRANK CO/ - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 158 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2015. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
RUSSELL FRANK CO/ ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2016$1,923,000
-76.2%
120,278
-56.3%
0.00%
-78.6%
Q4 2015$8,093,000
+62.6%
275,455
+57.5%
0.01%
+55.6%
Q3 2015$4,977,000
+3.2%
174,892
+30.3%
0.01%
+12.5%
Q2 2015$4,823,000
+24.7%
134,266
+101.8%
0.01%
+14.3%
Q1 2015$3,867,000
+108.9%
66,524
+19.2%
0.01%
+133.3%
Q3 2013$1,851,00055,8280.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2015
NameSharesValueWeighting ↓
ADVANTAGE INVESTMENT MANAGEMENT, LLC 105$00.00%
Sterling Investment Advisors, Ltd. 250$00.00%
Front Row Advisors LLC 60$00.00%
Executive Wealth Management, LLC 20$00.00%
BARCLAYS PLC 1,300$00.00%
BARCLAYS PLC 33,172$10,0000.00%
HUNTINGTON NATIONAL BANK 1$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Financial Gravity Asset Management, Inc. 50$00.00%
Vectors Research Management, LLC 505$00.00%
View complete list of INSYS THERAPEUTICS INC NEW shareholders